BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6227506)

  • 41. Metabolism of the plasma lipoproteins.
    Lewis B
    Sci Basis Med Annu Rev; 1972; ():118-44. PubMed ID: 4344060
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.
    Telimaa S; Penttilä I; Puolakka J; Rönnberg L; Kauppila A
    Fertil Steril; 1989 Jul; 52(1):31-5. PubMed ID: 2526031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High density lipoprotein and low density lipoprotein utilization by human granulosa cells for progesterone synthesis in serum-free culture: respective contributions of free and esterified cholesterol.
    Parinaud J; Perret B; Ribbes H; Chap H; Pontonnier G; Douste-Blazy L
    J Clin Endocrinol Metab; 1987 Mar; 64(3):409-17. PubMed ID: 3818885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary regulation of plasma lipoprotein metabolism in humans.
    Havel RJ
    Prog Biochem Pharmacol; 1983; 19():110-22. PubMed ID: 6338520
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
    Phillips NR; Havel RJ; Kane JP
    Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The physiology of lipoprotein metabolism].
    Assmann G
    Infusionsther Klin Ernahr; 1983 Aug; 10(4):162-70. PubMed ID: 6618657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Insulin-dependent diabetes and lipoprotein metabolism].
    Berthezène F; Perrot L; Valentin C; Sautot G
    Journ Annu Diabetol Hotel Dieu; 1984; ():115-23. PubMed ID: 6399527
    [No Abstract]   [Full Text] [Related]  

  • 49. Metabolism of triglyceride in rabbit plasma low and high density lipoproteins: studies in vivo and in vitro.
    Barter PJ; Lally JI; Wattchow D
    Metabolism; 1979 Jun; 28(6):614-8. PubMed ID: 221784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system.
    Eisenberg S
    Klin Wochenschr; 1983 Feb; 61(3):119-32. PubMed ID: 6843039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathways of lipoprotein metabolism: integration of structure, function and metabolism.
    Eisenberg S; Rachmilewitz D; Levy RI; Bilheimer DW; Lindgren FT
    Adv Exp Med Biol; 1975; 63():61-76. PubMed ID: 173155
    [No Abstract]   [Full Text] [Related]  

  • 53. Paradoxical effects of the anti-androgen cyproterone acetate on lipid and lipoprotein metabolism.
    Wynn V; Godsland IF; Seed M; Jacobs HS
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):183-91. PubMed ID: 2940034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
    JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
    Agheli N; Cloarec M; Jacotot B
    Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The transport of triglyceride in the high-density lipoproteins of human plasma.
    Barter PJ; Connor WE
    J Lab Clin Med; 1975 Feb; 85(2):260-72. PubMed ID: 163284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.